Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 157-163 , June 2010

Chronic bilirubin encephalopathy: diagnosis and outcome

References 

  1. Kumada S, Hayashi M, Umitsu R, et al. Neuropathology of the dentate nucleus in developmental disorders. Acta Neuropathol (Berl). 1997;94:36–41
  2. Ahdab-Barmada M, Moossy J. Kernicterus reexamined. Pediatrics. 1983;71:463–464
  3. Haymaker W, Margles C, Pentschew A. Pathology of kernicterus and posticteric encephalopathy. In:  Swinyard CA editors. Kernicterus and its importance in cerebral palsy. Springfield, IL: Charles C. Thomas; 1961;p. 21–229
  4. Blanc WA, Johnson L. Studies on kernicterus; relationship with sulfonamide intoxication, report on kernicterus in rats with glucuronyl transferase deficiency and review of pathogenesis. J Neuropath Exp Neurol. 1959;18:165–189
  5. Johnson L, Garcia ML, Figueroa E, Sarmiento F. Kernicterus in rats lacking glucuronyl transferase. Am J Dis Child. 1961;101:322–349
  6. Rose AL, Wisniewski H. Acute bilirubin encephalopathy induced with sulfadimethoxine in gunn rats. J Neuropathol Exp Neurol. 1979;38:152–165
  7. Johnston MV, Hoon AH. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol. 2000;15:588–591
  8. Claireaux AE. Pathology of human kernicterus. p. 140–149 Montreal: University of Toronto Press; 1961;
  9. Ahdab-Barmada M, Moossy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. J Neuropath Exp Neurol. 1984;43:45–56
  10. Malamud N. Pathogenesis of kernicterus in the light of its sequelae. In:  Swinyard CA editors. Kernicterus and its importance in cerebral palsy. Springfield, IL: Charles C. Thomas; 1961;p. 230–246
  11. Dublin W. Neurological lesions in erythroblastosis fetalis in relation to nuclear deafness. Am J Clin Pathol. 1951;21:935–939
  12. Gerrard J. Nuclear jaundice and deafness. J Laryngol Otol. 1952;66:39–46
  13. Kelemen G. Erythroblastosis fetalis. Pathologic report on the hearing organs of a newborn infant. Am Med Assoc Arch Otolaryngol. 1956;63:392–398
  14. Keino H, Kashiwamata S. Critical period of bilirubin-induced cerebellar hypoplasia in a new sprague-dawley strain of jaundiced gunn rats. Neurosci Res. 1989;6:209–215
  15. Conlee JW, Shapiro SM. Development of cerebellar hypoplasia in jaundiced gunn rats treated with sulfadimethoxine: a quantitative light microscopic analysis. Acta Neuropathologica. 1997;93:450–460
  16. Falcao AS, Fernandes A, Brito MA, Silva RF, Brites D. Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state. Acta Neuropathol (Berl). 2006;112:95–105
  17. Falcao AS, Fernandes A, Brito MA, Silva RF, Brites D. Bilirubin-induced inflammatory response, glutamate release, and cell death in rat cortical astrocytes are enhanced in younger cells. Neurobiol Dis. 2005;20:199–206
  18. de Vries LS, Lary S, Dubowitz LMS. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk, low birth-weight infants. Pediatrics. 1985;76:351–354
  19. de Vries LS, Lary S, Whitelaw AG, Dubowitz LM. Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Hum Dev. 1987;15:269–277
  20. Johnson L, Boggs TR. Bilirubin-dependent brain damage: incidence and indications for treatment. In:  Odell GB,  Schaffer R,  Sionpoulous AP editor. Phototherapy in the newborn: an overview. Washington: National Academy of Sciences; 1974;p. 122–149
  21. Ostrow JD, Pascolo L, Tiribelli C. Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res. 2003;54:98–104
  22. Van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics. 1961;28:870–876
  23. Volpe JJ. Bilirubin and brain injury. In:  Volpe JJ editors. Neurology of the newborn. 3rd ed.. Philadelphia: WB Saunders; 2001;p. 490–514
  24. Perlstein MA. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am. 1960;7:665–687
  25. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009;29(Suppl. 1):S25–S45
  26. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol. 2005;25:54–59
  27. Larroche JC. Kernicterus. In:  Vinken P,  Bruyn GW editor. Handbook of clinical neurology. Amsterdam: North-Holland; 1968;p. 491–515
  28. Byers RK, Paine RS, Crothers B. Extrapyramidal cerebral palsy with hearing loss following erythroblastosis. Pediatrics. 1955;15:248–254
  29. Hyman CB, Keaster J, Hanson V, et al. CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. A prospective study of 405 patients. Am J Dis Child. 1969;117:395–405
  30. Naeye RL. Amniotic fluid infections, neonatal hyperbilirubinemia and psychomotor impairment. Pediatrics. 1978;62:497–503
  31. Odell GB, Storey GN, Rosenberg LA. Studies in kernicterus. III. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr. 1970;76:12–21
  32. Rubin RA, Balow B, Fisch RO. Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. J Pediatr. 1979;94:601–604
  33. Scheidt PC. Toxicity to bilirubin in neonates: infant development during first year in relation to maximal neonatal serum bilirubin concentration. J Pediatr. 1977;92:292–297
  34. Bergman I, Hirsch RP, Fria TJ, et al. Cause of hearing loss in the high-risk premature infant. J Pediatr. 1985;106:95–101
  35. Salamy A, Eldredge L, Tooley WH. Neonatal status and hearing loss in high-risk infants. J Pediatr. 1989;114:847–852
  36. Rance G, Beer DE, Cone-Wesson B, et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear. 1999;20:238–252
  37. Simmons JL, Beauchaine KL. Auditory neuropathy: case study with hyperbilirubinemia. J Am Acad Audiol. 2000;11:337–347
  38. Powers KM, Miller S, Shapiro SM. Exposure to excessive hyperbilirubinemia earlier in neurodevelopment is associated with auditory-predominant kernicterus subtype. In: 37th Annual Meeting of the Child Neurology Society. Santa Clara, CA Annals of Neurology. 2008;64(Suppl.12):S105
  39. Rance G, Barker E, Mok M, et al. Speech perception in noise for children with auditory neuropathy/dys-synchrony type hearing loss. Ear Hear. 2007;28:351–360
  40. Rance G, Barker EJ, Sarant JZ, Ching TY. Receptive language and speech production in children with auditory neuropathy/dyssynchrony type hearing loss. Ear Hear. 2007;28:694–702
  41. Shallop JK, Peterson A, Facer GW, Fabry LB, Driscoll CL. Cochlear implants in five cases of auditory neuropathy: postoperative findings and progress. Laryngoscope. 2001;111(4 Pt 1):555–562
  42. Madden C, Hilbert L, Rutter M, Greinwald J, Choo D. Pediatric cochlear implantation in auditory neuropathy. Otol Neurotol. 2002;23:163–168
  43. Peterson A, Shallop J, Driscoll C, et al. Outcomes of cochlear implantation in children with auditory neuropathy. J Am Acad Audiol. 2003;14:188–201
  44. Wilson BA. In: Wilson reading system. 3rd ed.. Oxford, MA: Wilson Language Training; 1996;
  45. Wilson reading system. Denver: Education Commission of the States; 2002;
  46. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316

PII: S1744-165X(09)00123-1

doi: 10.1016/j.siny.2009.12.004

Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 157-163 , June 2010

Article Tools